Linked from

The 66 pages that link to Gene therapy, each with the reason it gives.

• Horizontal gene transferRelated: Viral vectors deliver therapeutic genes by a designed transfer between cells.

• Gene expressionRelated: Therapeutic designs can change expression of a target gene or supply a functional product.

• Molecular biologyRelated: It turns knowledge of genes and gene expression into therapeutic intervention.

• GeneRelated: Some therapies add, replace, or modify genes to change cell function.

• PlasmidRelated: Plasmids can deliver therapeutic genes in some experimental and clinical approaches.

• VirusRelated: Viral vectors are tools for delivering therapeutic genes.

• Recombinant DNARelated: Some gene therapies use engineered DNA constructs to supply or regulate genetic instructions.

• CRISPR-Cas9Related: Cas9 can be used to alter disease-associated sequences in therapeutic settings.

• Genetic engineeringRelated: Genetic engineering supplies methods for changing genes in therapeutic cells.

• Gene regulatory networkRelated: Therapies can target regulatory genes or alter expression in specific cells.

• Regenerative medicineRelated: It can support regeneration by changing cell behavior, but genetic modification alone is not tissue regeneration.

• CellRelated: Gene therapy targets cells to alter the instructions driving a disease.

• Duchenne muscular dystrophyRelated: Micro-dystrophin gene therapies aim to provide muscle cells with instructions for a shortened dystrophin protein.

• ImmunodeficiencyRelated: For selected inherited deficiencies, corrected stem cells can rebuild functional immune lineages.

• Severe combined immunodeficiencyRelated: For selected SCID types, corrected patient stem cells can restore production of the missing protein.

• Genetic disorderRelated: Some genetic disorders can be treated by replacing, editing, or regulating genetic material.

• Paul BergRelated: Gene therapy illustrates a later medical direction made possible by recombinant DNA techniques.

• Molecular geneticsRelated: Understanding genes at the molecular level enabled attempts to correct genetic disease.

• LeukodystrophyRelated: Gene therapies have become treatment options for selected leukodystrophies, including metachromatic leukodystrophy.

• AchromatopsiaRelated: Clinical research investigates gene replacement for specific inherited forms.

• Angelman syndromeRelated: UBE3A delivery is being studied as a way to restore gene function in affected neurons.

• Zinc finger nucleaseRelated: Zinc finger nucleases have been developed to modify disease-related genes in cells.

• Chronic granulomatous diseaseRelated: Gene addition is being developed to restore NADPH oxidase function in blood-forming cells.

• Emmanuelle CharpentierRelated: CRISPR-Cas9 has enabled experimental approaches to correcting disease-causing mutations.

• Human enhancementRelated: Gene-editing techniques raise the possibility of changing traits beyond disease treatment.

• OsteopetrosisRelated: Gene-based correction could target the inherited defect, but safe durable delivery remains challenging.

• TALENRelated: TALEN editing has been investigated as a way to modify therapeutic cells ex vivo.

• Primary immunodeficiencyRelated: For selected inherited immunodeficiencies, corrected patient cells can restore a missing gene function.

• Rett syndromeRelated: MECP2 replacement is under study, but precise dosage control is a major challenge.

• Alpha-1 antitrypsin deficiencyRelated: Researchers are investigating ways to restore alpha-1 antitrypsin production.

• HematologyRelated: It can address the inherited cause of some blood disorders, but durability and access remain concerns.

• Canavan diseaseRelated: Experimental approaches aim to restore ASPA function or reduce harmful metabolite accumulation.

• Epidermolysis bullosaRelated: Clinical approaches aim to restore functional skin proteins in selected EB forms.

• Usher syndromeRelated: Researchers are investigating gene-based treatments for specific Usher syndrome subtypes.

• Wiskott–Aldrich syndromeRelated: Clinical approaches aim to restore WAS gene function in a patient's blood-forming cells.

• ProgeriaRelated: A lasting therapy might reduce abnormal LMNA expression, but delivery and long-term safety remain challenges.

• CureRelated: Correcting or replacing a disease-causing gene can target an underlying cause.

• Metabolic disorderRelated: It offers a way to target some inherited causes of metabolic disease.

• Barth syndromeRelated: Correcting TAZ function is a research direction, not an established treatment for Barth syndrome.

• History of genetic engineeringRelated: Genetic engineering enabled therapies that alter patient cells to address disease.

• Molecular medicineRelated: It applies molecular understanding directly by changing disease-related genetic instructions.

• NucleofectionRelated: Nucleofection is a laboratory delivery technique relevant to ex vivo cell engineering, not itself a therapy.

• Oculocerebrorenal syndromeRelated: Correcting OCRL function is a potential research direction, but delivery to multiple affected tissues remains challenging.

• Regulation of gene expressionRelated: Therapies can aim to restore, suppress, or tune the expression of particular genes.

• Sanfilippo syndromeRelated: Investigational approaches aim to restore the missing enzyme and reduce substrate accumulation.

• Stargardt diseaseRelated: ABCA4-based approaches are under investigation, but no established gene therapy cures Stargardt disease.

• Stickler syndromeRelated: No established gene therapy currently corrects the underlying collagen defects in Stickler syndrome.